Rodenticide Toxicity Workup

  • Author: Derrick Lung, MD, MPH; Chief Editor: Asim Tarabar, MD   more...
 
Updated: Nov 16, 2011
 

Approach Considerations

Obtain the following tests in patients with possible rodenticide poisoning:

  • Glucose fingerstick - In every patient with altered mental status
  • Electrolytes, serum glucose level, and ketones - In patients suspected of exposure to PNU
  • Pregnancy tests - In women of childbearing age
  • Serum acetaminophen level - In every intentional exposure
  • Complete blood count (CBC) - In patients with evidence of bleeding or hemolysis
  • Creatine phosphokinase (CPK) and lactic acid - In patients suspected of exposure to strychnine (eg, "conscious seizures")

Measure PT and aPTT if the ingested substance is an anticoagulant. Possibly consider bleeding time and platelet count measurements in patients with evidence of bleeding. Requesting quantitative coagulation factors may be helpful, and these may be available far before actual analysis for suspect anticoagulant levels. Initial elevated PT and aPTT may suggest the possibility of chronic exposure.

Coagulation studies are expected to be normal in acute exposures to anticoagulants. These patients may require an international normalized ratio (INR) check on a daily basis for a couple days to rule out or confirm toxicity.

Because the availability of RBC cholinesterase is so poor, do not depend on supporting laboratory evidence when an exposure to an organophosphate-containing substance is suspected.

Laboratory verification of the anticoagulant rodenticides (eg, brodifacoum, difenacoum) is available; however, the result takes several days and is not necessary to guide therapy. Serial levels might only be helpful to estimate the drug half-life and duration of required therapy. In addition, blood tests for arsenic, thallium, mercury, and lead may be useful but are usually considerably time consuming.

Abdominal plain film radiography

If a metal rodenticide (eg, thallium, arsenic, barium) is considered, obtaining an abdominal plain film radiograph may be helpful, because these metals are radio-opaque.

Consultations

Consult with the regional poison control center or a medical toxicologist for additional information and patient care recommendations.

Obtain a psychiatric evaluation if the ingestion was intentional. Consult a hematologist or a medical toxicologist for long-term follow-up if a long-acting anticoagulant (eg, brodifacoum) was ingested.

Monitoring

Patients who ingest anticoagulant rodenticides and are discharged when their clotting studies are found to be normal may have delayed symptom onset and may continue to ingest the rodenticide once they are discharged. In these cases, the treating physician is responsible for proving that any sequela is not the result of a missed opportunity to treat. As previously stated, consult a hematologist or a medical toxicologist for long-term follow-up if a long-acting anticoagulant (eg, brodifacoum) was ingested.

 
 
Contributor Information and Disclosures
Author

Derrick Lung, MD, MPH  Fellow, Medical Toxicology, University of California, San Francisco, School of Medicine; Clinical Instructor, Division of Emergency Medicine, Stanford University Medical Center

Derrick Lung, MD, MPH is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Steven Marcus, MD  Professor, Department of Preventive Medicine and Community Health, Associate Professor, Department of Pediatrics, New Jersey Medical School, University of Medicine and Dentistry of New Jersey; Executive and Medical Director, New Jersey Poison Information and Education System; Consulting Staff, Departments of Pediatrics and Internal Medicine, University Hospital, University of Medicine and Dentistry of New Jersey; Consulting Staff, Department of Pediatrics, Newark Beth Israel Medical Center

Steven Marcus, MD is a member of the following medical societies: Academy of Medicine of New Jersey, American Academy of Clinical Toxicology, American Academy of Pediatrics, American College of Emergency Physicians, American College of Medical Toxicology, American Medical Association, and Medical Society of New Jersey

Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD  Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

Additional Contributors

Fred Harchelroad, MD, FACMT, FAAEM, FACEP Director of Medical Toxicology, Allegheny General Hospital

Disclosure: Nothing to disclose.

Assaad J Sayah, MD Chief, Department of Emergency Medicine, Cambridge Health Alliance

Assaad J Sayah, MD is a member of the following medical societies: National Association of EMS Physicians

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

References
  1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila). Dec 2010;48(10):979-1178. [Medline]. [Full Text].

  2. Decker WJ, Baker HE, Tamulinas SH, Korndorffer WE. Two deaths resulting from apparent parenteral injection of strychnine. Vet Hum Toxicol. Jun 1982;24(3):161-2. [Medline].

  3. O'Callaghan WG, Joyce N, Counihan HE, Ward M, Lavelle P, O'Brien E. Unusual strychnine poisoning and its treatment: report of eight cases. Br Med J (Clin Res Ed). Aug 14 1982;285(6340):478. [Medline].

  4. Spahr JE, Maul JS, Rodgers GM. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol. Jul 2007;82(7):656-60. [Medline].

  5. La Rosa FG, Clarke SH, Lefkowitz JB. Brodifacoum intoxication with marijuana smoking. Arch Pathol Lab Med. Jan 1997;121(1):67-9. [Medline].

  6. Nelson LS, Perrone J, DeRoos F, Stork C, Hoffman RS. Aldicarb poisoning by an illicit rodenticide imported into the United States: Tres Pasitos. J Toxicol Clin Toxicol. 2001;39(5):447-52. [Medline].

  7. Bruno GR, Howland MA, McMeeking A, Hoffman RS. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med. Sep 2000;36(3):262-7. [Medline].

  8. [Guideline] Caravati EM, Erdman AR, Scharman EJ, Woolf AD, Chyka PA, Cobaugh DJ, et al. Long-acting anticoagulant rodenticide poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(1):1-22. [Medline]. [Full Text].

  9. Papin F, Clarot F, Vicomte C, Gaulier JM, Daubin C, Chapon F. Lethal paradoxical cerebral vein thrombosis due to suspicious anticoagulant rodenticide intoxication with chlorophacinone. Forensic Sci Int. Mar 2 2007;166(2-3):85-90. [Medline].

  10. Laposata M, Van Cott EM, Lev MH. Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status. N Engl J Med. Jan 11 2007;356(2):174-82. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.